miR-216b suppresses glioma progression by targeting SREBP1-mediated lipid metabolic reprogramming

Lipid metabolic reprogramming contributes to glioma progression. Although miR-216b has tumor-suppressive effects in glioma, its role in lipid metabolism remains unclear. Gain- and loss-of-function assays assessed its effects on proliferation, colony formation, migration and invasion. Biotin-labelled miRNA pull-down, dual-luciferase reporter and AGO-RIP assays validated the interaction between miR-216b and SREBP1. Triglyceride measurement, BODIPY staining, Oil Red O staining and SREBP1 rescue experiments were performed to evaluate lipid accumulation and functional relevance. miR-216b was markedly downregulated in glioma cell, and its overexpression suppressed malignant phenotypes and lipid accumulation. Mechanistically, miR-216b directly targeted SREBP1 and reduced its expression, while SREBP1 restoration partially rescued lipid accumulation and malignant phenotypes suppressed by miR-216b. miR-216b suppresses glioma progression by targeting SREBP1-mediated lipid metabolic reprogramming, highlighting the miR-216b/SREBP1 axis as a potential therapeutic target in glioma.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-11-13
DOI
https://doi.org/10.1186/s12885-026-17182-w
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

miR-216b suppresses glioma progression by targeting SREBP1-mediated lipid metabolic reprogramming

Zirui Xia, Qing Liu, Fayou Zhou, Jun Liu et al.
1 links
BMC Cancer
MicroRNA in disease regulation
article

miR-216b suppresses glioma progression by targeting SREBP1-mediated lipid metabolic reprogramming

Zirui Xia, Qing Liu, Fayou Zhou, Jun Liu, Gang Chen, Hua Chen
article en

Abstract

Lipid metabolic reprogramming contributes to glioma progression. Although miR-216b has tumor-suppressive effects in glioma, its role in lipid metabolism remains unclear. Gain- and loss-of-function assays assessed its effects on proliferation, colony formation, migration and invasion. Biotin-labelled miRNA pull-down, dual-luciferase reporter and AGO-RIP assays validated the interaction between miR-216b and SREBP1. Triglyceride measurement, BODIPY staining, Oil Red O staining and SREBP1 rescue experiments were performed to evaluate lipid accumulation and functional relevance. miR-216b was markedly downregulated in glioma cell, and its overexpression suppressed malignant phenotypes and lipid accumulation. Mechanistically, miR-216b directly targeted SREBP1 and reduced its expression, while SREBP1 restoration partially rescued lipid accumulation and malignant phenotypes suppressed by miR-216b. miR-216b suppresses glioma progression by targeting SREBP1-mediated lipid metabolic reprogramming, highlighting the miR-216b/SREBP1 axis as a potential therapeutic target in glioma.

BMC Cancer
Wannan Medical College (CN), Dalian Medical University (CN), Anhui Medical University (CN), Second Affiliated Hospital of Anhui Medical University (CN), Jiangsu Province Hospital (CN), Nanjing Medical University (CN)
Good health and well-being
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon